Pharmacy benefit management unicorn Capital Rx hits $3.5 billion in revenue with a different approach to drug pricing as Congress targets middlemen
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...
Forbes4mon
The FTC Takes On Pharmaceutical Benefit Managers
A key concern is that pharma firms may raise their list prices in order to offer larger rebates ... The Value of Pharmacy Benefits Management, University of Chicago Economics Professor Cases ...